CATALAYER NEWS
Oncoinvent reaches halfway point in ovarian cancer trial enrollment
Source: Investing.com · 2026-06-18
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
Kistos takes FID on Balder Next project in Norway
2026-06-18
France’s Macron hosts Trump at Versailles Palace
2026-06-18
Citigroup pushes back Fed rate-cut timeline; sees cuts in Oct, Dec and Jan
2026-06-18
Costain wins £122m West Winch housing road contract
2026-06-18
iFOREX appoints Daniel Shalom as chief operating officer
2026-06-18
RELATED ON CATALAYER
Related Topics
AI Stocks News & AnalysisIn this story
REACHRELATED MARKETS
Prediction Markets